Back to Search
Start Over
The 2021 WHO classification of tumors of the central nervous system: A summary
- Source :
- Neuro-Oncology, 23(8), 1231-1251. Oxford University Press, Neuro-Oncology, Neuro-Oncology, Oxford University Press (OUP), 2021, 23 (8), pp.1231-1251. ⟨10.1093/neuonc/noab106⟩, Louis, D N, Perry, A, Wesseling, P, Brat, D J, Cree, I A, Figarella-Branger, D, Hawkins, C, Ng, H K, Pfister, S M, Reifenberger, G, Soffietti, R, von Deimling, A & Ellison, D W 2021, ' The 2021 WHO classification of tumors of the central nervous system: A summary ', Neuro-Oncology, vol. 23, no. 8, pp. 1231-1251 . https://doi.org/10.1093/neuonc/noab106, Neuro Oncol, Neuro-oncology, vol 23, iss 8, Neuro-Oncology, 2021, 23 (8), pp.1231-1251. ⟨10.1093/neuonc/noab106⟩
- Publication Year :
- 2021
-
Abstract
- The fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS), published in 2021, is the sixth version of the international standard for the classification of brain and spinal cord tumors. Building on the 2016 updated fourth edition and the work of the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy, the 2021 fifth edition introduces major changes that advance the role of molecular diagnostics in CNS tumor classification. At the same time, it remains wedded to other established approaches to tumor diagnosis such as histology and immunohistochemistry. In doing so, the fifth edition establishes some different approaches to both CNS tumor nomenclature and grading and it emphasizes the importance of integrated diagnoses and layered reports. New tumor types and subtypes are introduced, some based on novel diagnostic technologies such as DNA methylome profiling. The present review summarizes the major general changes in the 2021 fifth edition classification and the specific changes in each taxonomic category. It is hoped that this summary provides an overview to facilitate more in-depth exploration of the entire fifth edition of the WHO Classification of Tumors of the Central Nervous System.
- Subjects :
- Central Nervous System
Cancer Research
diagnosis
WHO Classification Summary
[SDV]Life Sciences [q-bio]
MESH: World Health Organization
MESH: Central Nervous System Neoplasms
Central Nervous System Neoplasms
0302 clinical medicine
Pathology
Medicine
Pathology, Molecular
Cancer
0303 health sciences
Brain
3. Good health
medicine.anatomical_structure
Oncology
classification
030220 oncology & carcinogenesis
brain tumor
Central nervous system
Oncology and Carcinogenesis
Brain tumor
World Health Organization
central nervous system
Humans
brian tumor
03 medical and health sciences
MESH: Brain
Rare Diseases
Taxonomy (general)
MESH: Central Nervous System
CNS TUMORS
Oncology & Carcinogenesis
Letters to the Editor
Grading (tumors)
030304 developmental biology
MESH: Pathology, Molecular
MESH: Humans
business.industry
Neurosciences
Molecular
medicine.disease
Brain Disorders
Brain Cancer
Neurology (clinical)
Who classification
business
Neuroscience
Subjects
Details
- Language :
- English
- ISSN :
- 15228517 and 15235866
- Database :
- OpenAIRE
- Journal :
- Neuro-Oncology, 23(8), 1231-1251. Oxford University Press, Neuro-Oncology, Neuro-Oncology, Oxford University Press (OUP), 2021, 23 (8), pp.1231-1251. ⟨10.1093/neuonc/noab106⟩, Louis, D N, Perry, A, Wesseling, P, Brat, D J, Cree, I A, Figarella-Branger, D, Hawkins, C, Ng, H K, Pfister, S M, Reifenberger, G, Soffietti, R, von Deimling, A & Ellison, D W 2021, ' The 2021 WHO classification of tumors of the central nervous system: A summary ', Neuro-Oncology, vol. 23, no. 8, pp. 1231-1251 . https://doi.org/10.1093/neuonc/noab106, Neuro Oncol, Neuro-oncology, vol 23, iss 8, Neuro-Oncology, 2021, 23 (8), pp.1231-1251. ⟨10.1093/neuonc/noab106⟩
- Accession number :
- edsair.doi.dedup.....bfabef93894e24461136ce1eb327c895
- Full Text :
- https://doi.org/10.1093/neuonc/noab106⟩